Effects of antihypertensive single-drug therapy on heart rate

Barry J Materson, D. J. Reda, D. W. Williams

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Heart rate increasingly is being recognized either as an independent risk factor for a wide variety of cardiovascular disorders or as a surrogate marker for them. We analyzed the changes in heart rate associated with antihypertensive therapy with six drugs and placebo from the VA Cooperative Study on Single-Drug Therapy. These results were published previously (American Journal of Hypertension 1998;11:597-601). This paper provides a summary of the earlier publication with the addition of three figures not previously published. Atenolol had the greatest effect on heart rate reduction, followed by clonidine and diltiazem-SR. Hydrochlorothiazide and captopril were associated with small reductions in heart rate over time, whereas prazosin increased heart rate. Patients whose blood pressure was controlled by placebo had a 3.1 beats/min reduction of heart rate at 2 years. When the baseline heart rate was 65 beats/min or less, all drugs increased the heart rate except for atenolol, which further reduced it. Although it is clear that each of the six drugs used in our study had a different effect on heart rate, we cannot state that drug-induced reduction in heart rate per se confers a decrease in cardiovascular risk.

Original languageEnglish
JournalAmerican Journal of Hypertension
Volume12
Issue number1 II SUPPL.
StatePublished - Mar 17 1999

Fingerprint

Antihypertensive Agents
Heart Rate
Drug Therapy
Atenolol
Pharmaceutical Preparations
Placebos
Diltiazem
Prazosin
Clonidine
Biomarkers
Blood Pressure
Hypertension

Keywords

  • Atenolol
  • Captopril
  • Clonidine
  • Diltiazem
  • Heart rate
  • Hydrochlorothiazide
  • Hypertension
  • Placebo
  • Prazosin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Materson, B. J., Reda, D. J., & Williams, D. W. (1999). Effects of antihypertensive single-drug therapy on heart rate. American Journal of Hypertension, 12(1 II SUPPL.).

Effects of antihypertensive single-drug therapy on heart rate. / Materson, Barry J; Reda, D. J.; Williams, D. W.

In: American Journal of Hypertension, Vol. 12, No. 1 II SUPPL., 17.03.1999.

Research output: Contribution to journalArticle

Materson, BJ, Reda, DJ & Williams, DW 1999, 'Effects of antihypertensive single-drug therapy on heart rate', American Journal of Hypertension, vol. 12, no. 1 II SUPPL..
Materson BJ, Reda DJ, Williams DW. Effects of antihypertensive single-drug therapy on heart rate. American Journal of Hypertension. 1999 Mar 17;12(1 II SUPPL.).
Materson, Barry J ; Reda, D. J. ; Williams, D. W. / Effects of antihypertensive single-drug therapy on heart rate. In: American Journal of Hypertension. 1999 ; Vol. 12, No. 1 II SUPPL.
@article{0268fa7123304ad9a266913470eff398,
title = "Effects of antihypertensive single-drug therapy on heart rate",
abstract = "Heart rate increasingly is being recognized either as an independent risk factor for a wide variety of cardiovascular disorders or as a surrogate marker for them. We analyzed the changes in heart rate associated with antihypertensive therapy with six drugs and placebo from the VA Cooperative Study on Single-Drug Therapy. These results were published previously (American Journal of Hypertension 1998;11:597-601). This paper provides a summary of the earlier publication with the addition of three figures not previously published. Atenolol had the greatest effect on heart rate reduction, followed by clonidine and diltiazem-SR. Hydrochlorothiazide and captopril were associated with small reductions in heart rate over time, whereas prazosin increased heart rate. Patients whose blood pressure was controlled by placebo had a 3.1 beats/min reduction of heart rate at 2 years. When the baseline heart rate was 65 beats/min or less, all drugs increased the heart rate except for atenolol, which further reduced it. Although it is clear that each of the six drugs used in our study had a different effect on heart rate, we cannot state that drug-induced reduction in heart rate per se confers a decrease in cardiovascular risk.",
keywords = "Atenolol, Captopril, Clonidine, Diltiazem, Heart rate, Hydrochlorothiazide, Hypertension, Placebo, Prazosin",
author = "Materson, {Barry J} and Reda, {D. J.} and Williams, {D. W.}",
year = "1999",
month = "3",
day = "17",
language = "English",
volume = "12",
journal = "Journal of clinical hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "1 II SUPPL.",

}

TY - JOUR

T1 - Effects of antihypertensive single-drug therapy on heart rate

AU - Materson, Barry J

AU - Reda, D. J.

AU - Williams, D. W.

PY - 1999/3/17

Y1 - 1999/3/17

N2 - Heart rate increasingly is being recognized either as an independent risk factor for a wide variety of cardiovascular disorders or as a surrogate marker for them. We analyzed the changes in heart rate associated with antihypertensive therapy with six drugs and placebo from the VA Cooperative Study on Single-Drug Therapy. These results were published previously (American Journal of Hypertension 1998;11:597-601). This paper provides a summary of the earlier publication with the addition of three figures not previously published. Atenolol had the greatest effect on heart rate reduction, followed by clonidine and diltiazem-SR. Hydrochlorothiazide and captopril were associated with small reductions in heart rate over time, whereas prazosin increased heart rate. Patients whose blood pressure was controlled by placebo had a 3.1 beats/min reduction of heart rate at 2 years. When the baseline heart rate was 65 beats/min or less, all drugs increased the heart rate except for atenolol, which further reduced it. Although it is clear that each of the six drugs used in our study had a different effect on heart rate, we cannot state that drug-induced reduction in heart rate per se confers a decrease in cardiovascular risk.

AB - Heart rate increasingly is being recognized either as an independent risk factor for a wide variety of cardiovascular disorders or as a surrogate marker for them. We analyzed the changes in heart rate associated with antihypertensive therapy with six drugs and placebo from the VA Cooperative Study on Single-Drug Therapy. These results were published previously (American Journal of Hypertension 1998;11:597-601). This paper provides a summary of the earlier publication with the addition of three figures not previously published. Atenolol had the greatest effect on heart rate reduction, followed by clonidine and diltiazem-SR. Hydrochlorothiazide and captopril were associated with small reductions in heart rate over time, whereas prazosin increased heart rate. Patients whose blood pressure was controlled by placebo had a 3.1 beats/min reduction of heart rate at 2 years. When the baseline heart rate was 65 beats/min or less, all drugs increased the heart rate except for atenolol, which further reduced it. Although it is clear that each of the six drugs used in our study had a different effect on heart rate, we cannot state that drug-induced reduction in heart rate per se confers a decrease in cardiovascular risk.

KW - Atenolol

KW - Captopril

KW - Clonidine

KW - Diltiazem

KW - Heart rate

KW - Hydrochlorothiazide

KW - Hypertension

KW - Placebo

KW - Prazosin

UR - http://www.scopus.com/inward/record.url?scp=0033020274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033020274&partnerID=8YFLogxK

M3 - Article

C2 - 10077414

AN - SCOPUS:0033020274

VL - 12

JO - Journal of clinical hypertension

JF - Journal of clinical hypertension

SN - 0895-7061

IS - 1 II SUPPL.

ER -